Infection and the Gut

Seminars in Pediatric Surgery

Volumn 12, Issue 4, 2003, Pages 265-274

  Blakelock, Russell T ^a,b   Beasley, Spencer W ^a,b  

^a Christchurch Hospital ^*

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; DIIODOHYDROXYQUIN; DOXYCYCLINE; ERYTHROMYCIN; IVERMECTIN; METRONIDAZOLE; PAROMOMYCIN; ROTAVIRUS VACCINE; TETRACYCLINE; TIABENDAZOLE; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE GASTROENTERITIS; AMEBIASIS; APPENDICITIS; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; CAMPYLOBACTER; CROHN DISEASE; CRYPTOSPORIDIOSIS; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; ESCHERICHIA COLI; FOOD POISONING; GASTROINTESTINAL SYMPTOM; GIARDIASIS; HUMAN; INTESTINE INFECTION; INTESTINE SURGERY; INTUSSUSCEPTION; NECROTIZING ENTEROCOLITIS; PARASITISM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SALMONELLA; SHIGELLA; STRONGYLOIDIASIS; TREATMENT INDICATION; VIBRIO CHOLERAE; VOMITING; YERSINIA;

EID: 0346895081     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2003.08.008     Document Type: Article

References (127)

1. Cheasty T, Rowe B: Antigenic relationships between the enteroinvasive Escherichia coli O antigens O28ac, O112ac, O124, O136, O143, O144, O152, and O164 and Shigella O antigens. J Clin Microbiol 17:681-684, 1983
2. Sereny B: Shigella keratoconjunctivitis: a preliminary report. Acta Microbiolo Acad Sci 2:293-296, 1955
3. Sears CL, Kaper JB: Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev 60:167-215, 1996
4. Law D: Virulence factors of Escherichia coli O157 and other Shiga toxin-producing E. coli. J Appl Microbiol 88:729-745, 2000
5. Karmali MA: Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 2:15-38, 1989
6. O'Brien AD, Lively TA, Chang TW, et al: Purification of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis. Lancet 2:573, 1983
7. O'Brien AO, Lively TA, Chen ME, et al: Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet 1:702, 1983
8. Mathewson JJ, Cravioto A: HEp-2 cell adherence as an assay for virulence among diarrheagenic Escherichia coli. J Infect Dis 159:1057-1060, 1989
9. Martin DL, MacDonald KL, White KE, et al: The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 323:1161-1167, 1990
10. Mathewson JJ, Oberhelman RA, Dupont HL: Enteroadherent Escherichia coli as a cause of diarrhea among children in Mexico. J Clin Microbiol 25:1917-1919, 1987
11. Bhan MK, Raj P, Levine MM, et al: Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis 159:1061-1064, 1989
12. Lacroix J, Delage G, Gosselin F, et al: Severe protracted diarrhea due to multiresistant adherent Escherichia coli. Am J Dis Child 138:693-696, 1984
13. Mathewson JJ, Johnson PC, DuPont HL, et al: A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. J Infect Dis 151:471-475, 1985
14. Eisenberg MS, Gaarslev K, Brown W, et al: Staphylococcal food poisoning aboard a commercial aircraft. Lancet 2:595-599, 1975
15. Levine WC, Bennett RW, Choi Y, et al: Staphylococcal food poisoning caused by imported canned mushrooms. J Infect Dis 173:1263-1267, 1996
16. Blaser MJ, Wells JG, Feldman RA, et al: Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med 98:360-365, 1983
17. Hansen MG, Pearl G, Levy M: Intussusception due to Yersinia enterocolitica enterocolitis in a patient with beta-thalassemia. Arch Pathol Lab Med 125:1486-1488, 2001
18. Janda JM, Powers C, Bryant RG, et al: Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp. Clin Microbiol Rev 1:245-267, 1988
19. He D, Sougioultzis S, Hagen S, et al: Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. Gastroenterology 122:1048-1057, 2002
20. Chen ML, Pothoulakis C, LaMont JT: Protein kinase C signaling regulates ZO-I translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J Biol Chem 277:4247-4254, 2002
21. Catrenich CE, Makin KM: Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms. Scand J Gastroenterol Suppl 181:58-64, 1991
22. Geis G, Suerbaum S, Forsthoff B, et al: Ultrastructure and biochemical studies of the flagellar sheath of Helicobacter pylori. J Med Microbiol 38:371-377, 1993
23. Lee A: The microbiology and epidemiology of Helicobacter pylori infection. Scand J Gastroenterol Suppl 201:2-6, 1994
24. Dunn BE, Cohen H, Blaser MJ: Helicobacter pylori. Clin Microbiol Rev 10:720-741, 1997
25. Blaser MJ: Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102:720-727, 1992
26. Parsonnet J: The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 9:45-51, 1995 (suppl 2)
27. Fraser AG, Scragg R, Metcalf P, et al: Prevalence of Helicobacter pylori infection in different ethnic groups in New Zealand children and adults. Aust N Z J Med 26:646-651, 1996
28. Uemura N, Okamoto S, Yamamoto S: H. pylori infection and the development of gastric cancer. Keio J Med 51:63-68, 2002 (suppl 2)
29. Nowicki MJ, Coyle WJ: Severe iron deficiency anemia and asymptomatic nodular gastroduodenitis: an uncommon presentation of Helicobacter pylori infection in a child. Clin Pediatr (Phila) 40:111-114, 2001
30. Matson DO, Estes MK, Glass RI, et al: Human calicivirus-associated diarrhea in children attending day care centers. J Infect Dis 159:71-78, 1989
31. Estes MK, Cohen J: Rotavirus gene structure and function. Microbiol Rev 53:410-449, 1989
32. Matson DO, Estes MK, Burns JW, et al: Serotype variation of human group A rotaviruses in two regions of the USA. J Infect Dis 162:605-614, 1990
33. Van R, Wun CC, O'Ryan ML, et al: Outbreaks of human enteric adenovirus types 40 and 41 in Houston day care centers. J Pediatr 120:516-521, 1992
34. Parashar UD, Monroe SS: "Norwalk-like viruses" as a cause of foodborne disease outbreaks. Rev Med Virol 11:243-252, 2001
35. Koopmans M, von Bonsdorff CH, Vinje J, et al: Foodborne viruses. FEMS Microbiol Rev 26:187-205, 2002
36. Bresee JS, Widdowson MA, Monroe SS, et al: Foodborne viral gastroenteritis: challenges and opportunities. Clin Infect Dis 35:748-753, 2002
37. Gotz H, Ekdahl K, Lindback J, et al: Clinical spectrum and transmission characteristics of infection with Norwalk-like virus: findings from a large community outbreak in Sweden. Clin Infect Dis 33:622-628, 2001
38. Nakata S, Estes MK, Graham DY, et al: Detection of antibody to group B adult diarrhea rotaviruses in humans. J Clin Microbiol 25:812-818, 1987
39. Bridger JC, Pedley S, McCrae MA: Group C rotaviruses in humans. J Clin Microbiol 23:760-763, 1986
40. Nazer H, Rice S, Walker-Smith JA: Clinical associations of stool astrovirus in childhood. J Pediatr Gastroenterol Nutr 1:555-558, 1982
41. Avery GB, Villavicencio O, Lilly JR, et al: Intractable diarrhea in early infancy. Pediatrics 41:712-722, 1986
42. Brandt CD, Kim HW, Rodriguez WJ, et al: Adenoviruses and pediatric gastroenteritis. J Infect Dis 151:437-443, 1985
43. Kotloff KL, Losonsky GA, Morris JG Jr, et al: Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings. Pediatrics 84:219-225, 1989
44. Ravdin JI: Amebiasis. Clin Infect Dis 20:1453-1464; quiz 1465-1456, 1995
45. Ericsson CD, Kohl S, Pickering LK, et al: Mechanisms of host defense in well nourished patients with chronic alcoholism. Alcohol Clin Exp Res 4:261-265, 1980
46. Ahmed L, el Rooby A, Kassem MI, et al: Ultrasonography in the diagnosis and management of 52 patients with amebic liver abscess in Cairo. Rev Infect Dis 12:330-337, 1990
47. Thompson RC: Giardiasis as a re-emerging infectious disease and its zoonotic potential. Int J Parasitol 30:1259-1267, 2000
48. Pickering LK, Engelkirk PG: Giardia lamblia. Pediatr Clin North Am 35:565-577, 1988
49. Current WL: Cryptosporidium: its biology and potential for environmental transmission. CRC Crit Rev Environ Control 17:21, 1986
50. Doyle MG, Pickering LK: Gastrointestinal infection in children with AIDS. Semin Pediatr Infect Dis 1:64, 1990
51. Chen XM, Keithly JS, Paya CV, et al: Cryptosporidiosis. N Engl J Med 346:1723-1731, 2002
52. Sonea IM, Palmer MV, Akili D, et al: Treatment with neurokinin-1 receptor antagonist reduces severity of inflammatory bowel disease induced by Cryptosporidium parvum. Clin Diagn Lab Immunol 9:333-340, 2002
53. Herwaldt BL: Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s. Clin Infect Dis 31:1040-1057, 2000
54. Liguory O, Sarfati C, Derouin F, et al: Evidence of different Enterocytozoon bieneusi genotypes in patients with and without human immunodeficiency virus infection. J Clin Microbiol 39:2672-2674, 2001
55. Lores B, Lopez-Miragaya I, Arias C, et al: Intestinal microsporidiosis due to Enterocytozoon bieneusi in elderly human immunodeficiency virus-negative patients from Vigo, Spain. Clin Infect Dis 34:918-921, 2002
56. Okhuysen PC: Traveler's diarrhea due to intestinal protozoa. Clin Infect Dis 33:110-114, 2001
57. Berk SL, Verghese A, Alvarez S, et al: Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med 147:1257-1261, 1987
58. Akgun Y: Intestinal obstruction caused by Ascaris lumbricoides. Dis Colon Rectum 39:1159-1163, 1996
59. Steinberg R, Davies J, Millar AJ, et al: Unusual intestinal sequelae after operations for Ascaris lumbricoides infestation. Pediatr Surg Int 19:85-87, 2003
60. Stephenson LS, Holland CV, Cooper ES: The public health significance of Trichuris trichiura. Parasitology 121:S73-95, 2000 (suppl)
61. Blumenthal DS. Intestinal nematodes in the United States. N Engl J Med 297:1437-1439, 1977
62. O'Brien AD, Holmes RK: Shiga and Shiga-like toxins. Microbiol Rev 51:206-220, 1987
63. Newland JW, Neill RJ: DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages. J Clin Microbiol 26:1292-1297, 1988
64. Goodgame RW: Understanding intestinal spore-forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora. Ann Intern Med 124:429-441, 1996
65. Knisley CV, Engelkirk PG, Pickering LK, et al: Rapid detection of giardia antigen in stool with the use of enzyme immunoassays. Am J Clin Pathol 91:704-708, 1989
66. Ungar BL, Yolken RH, Nash TE, et al: Enzyme-linked immunosorbent assay for the detection of Giardia lamblia in fecal specimens. J Infect Dis 149:90-97, 1984
67. Walsh JA: Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 8:228-238, 1986
68. Ungar BL: Enzyme-linked immunoassay for detection of Cryptosporidium antigens in fecal specimens. J Clin Microbiol 28:2491-2495 1990
69. Garcia LS, Brewer TC, Bruckner DA: Incidence of Cryptosporidium in all patients submitting stool specimens for ova and parasite examination: monoclonal antibody IFA method. Diagn Microbiol Infect Dis 11:25-27, 1988
70. Rusnak J, Hadfield TL, Rhodes MM, et al: Detection of Cryptosporidium oocysts in human fecal specimens by an indirect immunofluorescence assay with monoclonal antibodies. J Clin Microbiol 27:1135-1136, 1989
71. Didier ES, Orenstein JM, Aldras A, et al: Comparison of three staining methods for detecting microsporidia in fluids. J Clin Microbiol 33:3138-3145, 1995
72. Weber R, Bryan RT, Owen RL, et al: Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group. N Engl J Med 326:161-166, 1992
73. da Silva AJ, Schwartz DA, Visvesvara GS, et al: Sensitive PCR diagnosis of Infections by Enterocytozoon bieneusi (microsporidia) using primers based on the region coding for small-subunit rRNA. J Clin Microbiol 34:986-987, 1996
74. Fedorko DP, Nelson NA, Cartwright CP: Identification of microsporidia in stool specimens by using PCR and restriction endonucleases. J Clin Microbiol 33:1739-1741, 1995
75. Rosenthal P, Liebman WM: Comparative study of stool examinations, duodenal aspiration, and pediatric Entero-Test for giardiasis in children. J Pediatr 96:278-279, 1980
76. Lew JF, LeBaron CW, Glass RI, et al: Recommendations for collection of laboratory specimens associated with outbreaks of gastroenteritis. MMWR Recomm Rep 39:1-13, 1996
77. Dennehy PH, Gauntlett DR, Tente WE: Comparison of nine commercial immunoassays for the detection of rotavirus in fecal specimens. J Clin Microbiol 26:1630-1634, 1988
78. Rumack BH, Temple AR: Lomotil poisoning. Pediatrics 53:495-500, 1974
79. Provisional Committee on Quality Improvement SoAG, American Academy of Pediatrics: Practice parameter: The management of acute gastroenteritis in young children. Pediatrics 97:424-436, 1996
80. Motala C, Hill ID, Mann MD, et al: Effect of loperamide on stool output and duration of acute infectious diarrhea in infants. J Pediatr 117:467-471, 1990
81. Saavedra JM, Bauman NA, Oung I, et al: Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046-1049, 1994
82. Elmer GW, Surawicz CM, McFarland LV: Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275:870-876, 1996
83. Harder A, Greif G, Haberkorn A: Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba-current level of knowledge and outlook. Parasitol Res 87:785-786, 2001
84. Nash TE, Ohl CA, Thomas E, et al: Treatment of patients with refractory giardiasis. Clin Infect Dis 33:22-28, 2001
85. Kosloske AM: Necrotizing enterocolitis, in Oldham KT, Colombani PM, Foglia RP (eds): Surgery of Infants and Children: Scientific Principles and Practice, Philadelphia, Lippincott-Raven, 1997, pp 1201-1213
86. Santulli TV, Schullinger JN, Heird WC, et al: Acute necrotizing enterocolitis in infancy: a review of 64 cases. Pediatrics 155:376-387, 1975
87. Kosloske AM: A unifying hypothesis for pathogenesis and prevention of necrotizing enterocolitis. J Pediatr 117:S68-74, 1990
88. Wiswell TE, Robertson CF, Jones TA, et al: Necrotizing enterocolitis in full-term infants. A case-control study. Am J Dis Child 142:532-535, 1988
89. Guinan M, Schaberg D, Bruhn FW, et al: Epidemic occurrence of neonatal necrotizing enterocolitis. Am J Dis Child 133:594-597, 1979
90. Book LS, Overall JC Jr, Herbst JJ, et al: Clustering of necrotizing enterocolitis. Interruption by infection-control measures. N Engl J Med 297:984-986, 1977
91. Blakey JL, Lubitz L, Campbell NT, et al: Enteric colonization in sporadic neonatal necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 4:591-595, 1985
92. Hill HR, Hunt CE, Matsen JM: Nosocomial colonization with Klebsiella, type 26, in a neonatal intensive-care unit associated with an outbreak of sepsis, meningitis, and necrotizing enterocolitis. J Pediatr 85:415-419, 1974
93. Howard FM, Flynn DM, Bradley JM, et al: Outbreak of necrotising enterocolitis caused by Clostridium butyricum. Lancet 2:1099-1102, 1977
94. Kliegman RM, Fanaroff AA, Izant R, et al: Clostridia as pathogens in neonatal necrotizing enterocolitis. J Pediatr 95:287-289, 1979
95. Cashore WJ, Peter G, Lauermann M, et al: Clostridia colonization and clostridial toxin in neonatal necrotizing enterocolitis. J Pediatr 98:308-311, 1981
96. Perez-Gonzalez J, Ventura Faci MP, Samper Villagrasa MP, et al: [An epidemic outbreak of necrotizing enterocolitis due to Clostridium difficile in term newborn infants]. An Esp Pediatr 44:173-175, 1996
97. Johnson FE, Crnic DM, Simmons MA, et al: Association of fatal Coxsackie B2 viral infection and necrotizing enterocolitis. Arch Dis Child 52:802-804, 1977
98. Alfa MJ, Robson D, Davi M, et al: An outbreak of necrotizing enterocolitis associated with a novel clostridium species in a neonatal intensive care unit. Clin Infect Dis 35:S101-105, 2002
99. Kosloske AM, Ball WS Jr, Umland E, et al: Clostridial necrotizing enterocolitis. J Pediatr Surg 20:155-159, 1985
100. Hoy C, Millar MR, MacKay P, et al: Quantitative changes in faecal microflora preceding necrotising enterocolitis in premature neonates. Arch Dis Child 65:1057-1059, 1990
101. Scheifele DW, Bjornson GL, Dyer RA, et al: Delta-like toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis. Infect Immun 55:2268-2273, 1987
102. Bousseboua H, Le Coz Y, Dabard J, et al: Experimental cecitis in gnotobiotic quails monoassociated with Clostridium butyricum strains isolated from patients with neonatal necrotizing enterocolitis and from healthy newborns. Infect Immun 57:932-936, 1989
103. Paik SY, Oh JT, Choi YJ, et al: Measles-related appendicitis. Arch Pathol Lab Med 126:82-84, 2002
104. Andersen BR, Kallehave FL, Andersen HK: Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. (Cochrane Review). Cochrane Database of Systematic Reviews 1, 2003
105. Hsu HY, Kao CL, Huang LM, et al: Viral etiology of intussusception in Taiwanese childhood. Pediatr Infect Dis J 17:893-898, 1998
106. Verstraeten T, Baughman AL, Cadwell B, et al: Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol 154:1006-1012, 2001
107. Offit PA: The future of rotavirus vaccines. Semin Pediatr Infect Dis 13:190-195, 2002
108. Cunliffe NA, Bresee JS, Hart CA: Rotavirus vaccines: development, current issues and future prospects. J Infect 45:1-9, 2002
109. Murphy TV, Smith PJ, Gargiullo PM, et al: The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. J Infect Dis 187:1309-1313, 2003
110. Hermon-Taylor J, Bull TJ, Sheridan JM, et al: Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can J Gastroenterol 14:521-539, 2000
111. Hermon-Taylor J, Bull T, Bull TJ, et al: Crohn's disease caused by Mycobacterium avium subspecies paratuberculosis: a public health tragedy whose resolution is long overdue. J Med Microbiol 51:3-6, 2002
112. Grant IR, Ball HJ, Rowe MT: Effect of higher pasteurization temperatures, and longer holding times at 72 degrees C, on the inactivation of Mycobacterium paratuberculosis in milk. Lett Appl Microbiol 28:461-465, 1999
113. Food Standards Agency UK: Press release: Agency plans action on milk bug. http://www.foodstandards.gov.uk/news/pressreleases/milkbug. Vol. 2003, 2000
114. Beard PM, Daniels MJ, Henderson D, et al: Paratuberculosis infection of nonruminant wildlife in Scotland. J Clin Microbiol 39:1517-1521, 2001
115. Harris NB, Barletta RG: Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine. Clin Microbiol Rev 14:489-512, 2001
116. Riis L, Vind I, Prioe T, et al: The Danish Crohn colitis Remicade Database. Three years clinical experience. Gastroenterology 122:A-609, 2002
117. Stephens MC, Shepanski MA, Mamula PZ, JE, et al: Experience using inflixitab for Crohn disease at a pediatric infammatory disease center. Gastroenterology 122:A-12, 2002
118. Fleisher M, Rubin SD, Levine AE, et al: Infliximab treatment of steroid refractory erythema nodosum. Gastroenterology 122:A-618, 2002
119. Foster EN, Nguyen KK, Bolce RJ, et al: Cutaneous manifestations of inflammatory bowel disease improve with infliximab therapy. Gastroenterology 122:A-618, 2002
120. Regueiro M, Plevy S, Valentine J, et al: Successful treatment of IBD-associated pyoderma gangrenosum with infliximab. Gastroenterology 122:A-616, 2002
121. Oliva-Hemker M, Roper S, Cuffari C, et al: Infliximab therapy for pediatric Crohn's disease. Gastroenterology 122:A-612, 2002
122. Crandall WV, Mackner LM: Adverse reactions in children and adolescents following infliximab infusions. Gastroenterology 122:A-614, 2002
123. Mow WS, Abreu MT, Papadakis KA, et al: High incidence of anergy limits the usefulness of PPD screening for tuberulosis (TB) prior to Remicade in inflammatory bowel disease (IBD). Gastroenterology 122:A-100, 2002
124. Aberra FN, McGregor J, Brennan PR, et al: Is a PPD skin test result sufficient in determining risk for reactivation of latent TB infection in IBD patients that are candidates for infliximab therapy. Gastroenterology 122:A-617, 2002
125. Carne P, Frizelle P: Cytomegalovirus and inflammatory bowel disease. N Z Med J 116:306, 2003
126. Cottone M, Pietrosi G, Martorana G, et al: Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 96:773-775, 2001
127. Pickering LK, Cleary T: Approach to patients with gastrointestinal tract infections and food poisoning, in Feigin RD, Cherry JD (eds): Textbook of Paediatric Infectious Disease (ed 4, vol 1). Philadelphia, WB Saunders, 1998, pp 567-601